whitepaper

Article: Pharma’s response to COVID-19: What’s next?

Posted: 26 June 2020 | | No comments yet

COVID-19 has affected nearly every Pharma industry. The development of a vaccine is challenging the world’s finest researchers and clinicians.

Clinical trials are underway to develop a vaccine and identify potential therapeutics, but management of the virus continues to bewilder the world’s finest researchers and clinicians. As a result, many of the social-distancing measures intended to prevent spread remain firmly in place, significantly altering the way life is lived and business is conducted.

READ MORE

Related organisations

Send this to a friend